Q2 2026 · Form 13F Ledger数据来源:SEC EDGAR  
H

HOLDER.TOP

谁持有什么——美股机构持仓的季度账本。
EN · 简 · 繁
机构 / Eversept Partners, LP
Form 13F · Q2 2026

Eversept Partners, LP

CIK 1697013申报日 2026-08-1413F-HR 在 EDGAR 查看原始申报 ↗
$19.3亿
申报组合市值
120
持仓数量
12
Quarters on record
Top 50
持仓数量

Eversept Partners, LP——持仓

共 120 个持仓中的前 50 名,按申报市值排名。股数变动与上一季度对比。
#证券股数股数环比市值占其组合
1UTHR United Therapeutics Corp Del287,668+8.9%$1.6亿8.1%
2ABVX Abivax Sa913,880−2.2%$1.2亿6.3%
3EHC Encompass Health Corp1.0M+429.1%$1.0亿5.4%
4ENSG Ensign Group Inc602,079+3978.8%$9651万5.0%
5VERA Vera Therapeutics Inc2.2M+1.8%$9495万4.9%
6CLDX Celldex Therapeutics Inc New1.8M−0.1%$6645万3.4%
7SNDX Syndax Pharmaceuticals Inc2.8M−3.0%$6117万3.2%
8BKD Brookdale Sr Living Inc3.4M−4.8%$5465万2.8%
9IONS Ionis Pharmaceuticals Inc664,684+5.2%$5270万2.7%
10NTRA Natera Inc175,807−54.3%$4772万2.5%
11TVTX Travere Therapeutics Inc798,973+47.2%$4539万2.4%
12CTRE Caretrust Reit Inc1.1M—$4326万2.2%
13HCA Hca Healthcare Inc98,252+24.0%$3831万2.0%
14PCVX Vaxcyte Inc629,952−31.8%$3662万1.9%
15LQDA Liquidia Corporation428,652−36.7%$3418万1.8%
16CYH Community Health Sys Inc New7.9M−9.4%$2627万1.4%
17GSK Gsk Plc481,833−73.0%$2526万1.3%
18CHE Chemed Corp New52,523+69.1%$2446万1.3%
19LLY Eli Lilly & Co20,116+5.9%$2413万1.3%
20GERN Geron Corp18.7M−0.6%$2396万1.2%
21VKTX Viking Therapeutics Inc602,922+152.2%$2352万1.2%
22OHI Omega Healthcare Invs Inc483,547−17.4%$2306万1.2%
23PODD Insulet Corp148,816+3.7%$2266万1.2%
24THC Tenet Healthcare Corp114,199+287.0%$2136万1.1%
25UNH Unitedhealth Group Inc51,145—$2126万1.1%
26WELL Welltower Inc87,312−51.7%$1982万1.0%
27BBNX Beta Bionics Inc1.2M−11.7%$1958万1.0%
28COGT Cogent Biosciences Inc490,235—$1897万1.0%
29BCRX Biocryst Pharmaceuticals Inc1.9M−38.6%$1866万1.0%
30MOH Molina Healthcare Inc80,594+145.6%$1843万1.0%
31PNTG Pennant Group Inc460,272+47.4%$1701万0.9%
32LTC Ltc Pptys Inc420,640+31.0%$1617万0.8%
33INSM Insmed Inc149,209—$1591万0.8%
34VRDN Viridian Therapeutics Inc831,142+16.5%$1527万0.8%
35BMRN Biomarin Pharmaceutical Inc249,607+20.1%$1428万0.7%
36AMN Amn Healthcare Svcs Inc428,531—$1387万0.7%
37CELC Celcuity Inc127,931—$1338万0.7%
38PHVS Pharvaris N V386,383−5.1%$1336万0.7%
39CTMX Cytomx Therapeutics Inc.3.6M+11.6%$1334万0.7%
40HUM Humana Inc31,171—$1238万0.6%
41XENE Xenon Pharmaceuticals Inc196,532+51.7%$1186万0.6%
42CRVS Corvus Pharmaceuticals Inc747,994—$1118万0.6%
43ASND Ascendis Pharma A/S41,621—$1110万0.6%
44BRKR Bruker Corp182,894+56.3%$1101万0.6%
45MRNA Moderna Inc152,122−4.7%$1065万0.6%
46GPCR Structure Therapeutics Inc196,302+42.2%$1054万0.5%
47DFTX Definium Therapeutics Inc217,185+35.1%$1022万0.5%
48CMPS Compass Pathways Plc672,825−0.8%$952万0.5%
49NAMS Newamsterdam Pharma Company275,471−3.6%$934万0.5%
50RVTY Revvity Inc83,624−1.4%$930万0.5%
来源:经 SEC EDGAR 的 Form 13F 申报。持仓截至 2026 年 6 月 30 日。期权(看涨/看跌)不计入股数。